Stock Market Watch

Hospira sees Q3 EPS and revenues below consensus

by ·




Hospira, Inc. (NYSE:HSP). Last Market Price: 30.18, Change: -7.18, % Change: (-19.22%). Shares trade in the range of 29.16 – 30.74 dollars. It has a market capitalization of 4.98B dollars, making it a Mid Cap Stock and has 164.87M outstanding shares. The company has a beta of 0.83, indicating, the stock to be less volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is 2.51; P/E of 12.04. It operates in Healthcare sector and belongs to Biotechnology and Drugs industry. Percentage shares held by institutional investors is 90%. The company has a 52 week high of $ 60.49 and a 52 week low of $ 29.16. Average volumes of shares traded daily are 1,750,000. Volume traded in the last session was at 9,690,000, 5.54 times the average volume.

  • Company sees preliminary Q3 results below consensus; sees adjusted EPS of $0.66 ; Revenues $977 million
  • Company also lowers FY11 adjusted EPS to $2.95-3.05 from $3.90-4.00 vs. $3.92

For Q2 (Jun ’11), It had a Net profit margin of 12.40%, an Operating margin of 17.90%. Other Key stats and ratios are : Return on average assets of 8.40%, Return on average equity of 16.63%. The organization has an employee strength of 14,000

Consensus Recommendation is a Outperform.


Estimate for sales for the Year Ending Dec-11 show a mean of 4,224.49 million dollars, an estimate high of 4,306.52 million dollars and an estimate low of 4,036.60 million dollars. A year ago the figures stood at 4,286.73 million dollars.

Estimate for sales for the Year Ending Dec-12 show a mean of 4,482.38 million dollars, an estimate high of 4,800.00 million dollars and an estimate low of 4,316.61 million dollars. A year ago the figures stood at 4,621.48 million dollars.

Estimate for EPS for the Year Ending Dec-11 show a mean of 3.93 dollars, an estimate high of 4.00 dollars and an estimate low of 3.87 dollars. A year ago the figures stood at 4.20 dollars.

Estimate for EPS for the Year Ending Dec-12 show a mean of 4.16 dollars, an estimate high of 4.62 dollars and an estimate low of 3.90 dollars. A year ago the figures stood at 4.71 dollars.

Sales for Quarter Ending Jun-11 was estimated at 970.64 million dollars, however the actual sales figure stood at 1,064.10 million dollars, 93.46 million dollars more than estimates.

Sales for Quarter Ending Mar-11 was estimated at 948.26 million dollars, however the actual sales figure stood at 1,002.30 million dollars, 54.04 million dollars more than estimates.

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...